...
首页> 外文期刊>Acta Poloniae Pharmaceutica: Durg Research >DEVELOPMENT AND VALIDATION OF GAS CHROMATOGRAPHY METHODS FOR THE CONTROL OF VOLATILE IMPURITIES IN THE PHARMACEUTICAL SUBSTANCE DUTASTERIDE
【24h】

DEVELOPMENT AND VALIDATION OF GAS CHROMATOGRAPHY METHODS FOR THE CONTROL OF VOLATILE IMPURITIES IN THE PHARMACEUTICAL SUBSTANCE DUTASTERIDE

机译:荷兰特德药物杂散控制挥发性杂质气相色谱法的发展与验证

获取原文
获取原文并翻译 | 示例

摘要

Dutasteride, N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5α-androst-l-ene-17β-carboxamide, is an active pharmaceutical ingredient (API) which inhibits the conversion of testosterone to dihydrotestosterone. As a 5-reductase inhibitor dutasteride is useful for the treatment of benign prostatic hyperplasia (BPH) and prostate cancer. Because of a large variety of solvents and reagents used in the synthesis, it was necessary to develop new, sensitive and selective gas chromatography (GC) methods. The optimization of the methods consisted in selecting different types of the sample injection and detection as well as the optimization of experimental conditions that allowed to meet the appropriate range of permissible limits and suitable detection limits (LOD) of compounds. Significant differences in the volatility of these compounds forced the division into volatile solvents (methanol, acetonitrile, dichloromethane, ethyl acetate, heptane and toluene) analyzed with the use of the gas chromatography method with headspace (GC-HS) and less volatile compounds (pyridine, dimethylformamide, 1,4-dioxane, acetic acid, ethylene glycol, 4-dimethylaminopyridine) which were analyzed using gas chromatography with direct injection (GC-F1D). Benzene, carbon tetrachloride and 1,2- dichloroethane are potential contaminants of toluene and dichloromethane, thus the control of these solvents was a limit test procedure. Due to the low permissible limits for benzene (2 μg/mL), carbon tetrachloride (4 μg/mL) and 1,2-dichloroethane (5 μg/mL) it was necessary to use gas chromatography with a mass spectrometry detector (GC-MS). All three new methods were validated according to the requirements of the ICH (International Conference on Harmonization) validation guideline Q2R1 and the Q3C guideline for residual solvents. Specificity, precision, accuracy, linearity, limits of detection and quantitation as well as robustness were determined and the results meeting the acceptance criteria were obtained.
机译:Dutasteride,N- [2,5-双(三氟甲基)苯基] -3-氧代-4- AZA-5α-ANDROST-L-ENE-17β-甲酰胺是一种活性药物成分(API),其抑制睾酮转化对二氢睾酮。作为5-还原酶抑制剂荷兰特德可用于治疗良性前列腺增生(BPH)和前列腺癌。由于合成中使用的各种溶剂和试剂,因此需要开发新的,灵敏和选择性气相色谱(GC)方法。这些方法的优化包括选择不同类型的样品喷射和检测以及优化的实验条件,其允许满足化合物的适当范围的允许范围和合适的检测限制(LOD)。通过使用具有顶空(GC-HS)的气相色谱法和挥发性化合物(吡啶的挥发性化合物(吡啶使用气相色谱(GC-F1D)分析,分析,使用气相色谱(GC-F1d),分析二甲基甲酰胺,1,4-二恶烷,乙酸,乙二醇,4-二甲基氨基吡啶)。苯,四氯化碳和1,2-二氯乙烷是甲苯和二氯甲烷的潜在污染物,因此对这些溶剂的控制是限制试验程序。由于苯的低允许限制(2μg/ ml),四氯化碳(4μg/ ml)和1,2-二氯乙烷(5μg/ ml)必须使用气相色谱法与质谱探测器(GC-多发性硬化症)。所有三种新方法都是根据ICH(协调会议)验证指南Q2R1和Q3C残留溶剂的Q3C指南的要求验证。确定了特异性,精度,精度,线性度,测定了检测和定量的限制,并获得了满足验收标准的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号